Streetbeat News

Earnings

FDIS

TSLA

XLY

Tesla Inc (NASDAQ:TSLA) has rescinded internship offers due to budget constraints, leaving many students in a difficult position. The company's decision is part of broader cost-cutting measures, including a 10% global workforce reduction announced by CEO Elon Musk. This comes amid concerns over declining electric vehicle sales and high expenditures, with Tesla reporting an 8.5% year-on-year decline in first-quarter deliveries. The company also plans to slow down the expansion of its supercharger network. Despite these challenges, Tesla stock has gained over 12% in the last 12 months, and investors can gain exposure to Tesla through ETFs like the Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) and Fidelity MSCI Consumer Discretionary Index ETF (NYSE:FDIS).

Portfolio Pulse from Shivani Kumaresan

May 02, 2024 | 3:04 pm

UGI

UGI shares are trading lower following the announcement of Q2 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:03 pm

RXO

RXO shares have experienced an increase in trading following the announcement of their Q1 adjusted EPS results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:02 pm

PJT

PJT Partners shares are trading higher following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:01 pm

FORM

In the last three months, 4 analysts have shared diverse evaluations of FormFactor (NASDAQ:FORM), with recent ratings showing a positive shift. The average 12-month price target for FORM has risen by 16.46% to $47.75. Analysts from Needham and Stifel, among others, have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. FormFactor, specializing in semiconductor probe card products, has shown solid financial performance with a notable revenue growth rate of 1.31% and exceptional net margin of 45.1%.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:01 pm

MYRG

MYR Group's shares declined following the announcement of disappointing Q1 financial results. Additionally, Baird reaffirmed an Outperform rating but reduced the price target from $185 to $180.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:01 pm

PLTR

Palantir Technologies (NYSE:PLTR) is analyzed in comparison to its competitors in the Software industry, highlighting its financial metrics and market standing. Despite trading at a premium with high PE, PB, and PS ratios, Palantir shows potential inefficiencies in resource utilization, evidenced by its low ROE, EBITDA, and gross profit. However, its revenue growth outpaces the industry average, indicating strong sales expansion and market share gain.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

REGN

The analysis compares Regeneron Pharmaceuticals (REGN) against its competitors in the Biotechnology industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Regeneron shows potential undervaluation based on its P/E, P/B, and P/S ratios compared to industry averages. However, its ROE is below the industry average, suggesting inefficiency in using equity to generate profits. Despite this, Regeneron's EBITDA and gross profit are above the industry average, indicating strong operational performance. The company's revenue growth is significantly lower than the industry average, highlighting a challenging sales environment.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

SMCI

The analysis compares Super Micro Computer (SMCI) with its competitors in the Technology Hardware, Storage & Peripherals industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. SMCI shows potential for growth with a P/E ratio lower than the industry average, suggesting undervaluation. However, its lower ROE, EBITDA, and gross profit compared to the industry suggest operational challenges. Notably, SMCI's revenue growth outperforms the industry average, indicating strong demand for its products.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

GKOS

Glaukos shares surged following the announcement of Q1 sales surpassing expectations and the company providing optimistic FY24 net sales guidance. Additionally, several firms have increased their price targets for Glaukos.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 2:59 pm